Forbes India - Alan Auerbach: Puma Biotech's Overnight Billionaire
Puma Shares Soar 81% Over 2 Days - Los Angeles Business Journal
Chelsea Dickey - Finance Manager - Puma Biotechnology, Inc. | LinkedIn
Puma Biotech shares slide after glimpse of trial data on cancer drug | Financial Times
Puma Biotechnology Aktie (A1J643,US74587V1070) | Kurs - Finanzen100
Hospitals in Western U.S. Under Siege as Covid-19 Packs ICUs
Puma Shares Soar 81% Over 2 Days - Los Angeles Business Journal
OpenBB wants to be an open source challenger to Bloomberg Terminal - JackOfAllTechs.com
Puma Biotechnology (NASDAQ:PBYI) Has Debt But No Earnings; Should You Worry?
Hospitals in Western U.S. Under Siege as Covid-19 Packs ICUs
Puma Biotechnology Surging
Nerlynx's setback in Europe creates uncertainty for Puma Biotechnology Inc
Crypto Asset Manager Grayscale Launches 'Future of Finance' ETF in Partnership With Bloomberg - JackOfAllTechs.com
ASCO may mean big stock moves ahead for Puma, Clovis
Hospitals in Western U.S. Under Siege as Covid-19 Packs ICUs
Alan H Auerbach, Puma Biotechnology Inc: Profile and Biography - Bloomberg Markets
China SPACs Spooked by Mounting Red Tape - Bloomberg
DFAN14A
APHINITY' Study Spells Major Trouble for Roche, Another Win for Puma Bio - TheStreet
Celcuity to conduct study with Puma in breast cancer with brain metastases | Seeking Alpha
GlaxoSmithKline's $5.1 Billion Tesaro Deal Spurs M&A Hopes
Puma's Nerlynx unleashed to fight HER2+ breast cancer with 'best case' label | Fierce Pharma
Chelsea Dickey - Finance Manager - Puma Biotechnology, Inc. | LinkedIn
Do Insiders Own Lots Of Shares In Puma Biotechnology, Inc. (NASDAQ:PBYI)? | Nasdaq
